Egyptian Firm Develops Ebola Vaccine for DRC Outbreak
Egyptian pharmaceutical company Minapharm is developing a potential vaccine against the Bundibugyo strain of Ebola amid an outbreak in the Democratic Republic of Congo (DRC). The company will receive up to $16.5 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance development of the vaccine, according to a joint statement released on Thursday….
